









市場行情
/
股票
/
nasdaq-neo
/

Neogenomics Inc

NEO

12.280USD

-0.020-0.16%

收盤 12/26, 16:00（美東）報價延遲15分鐘

1.58B總市值

虧損本益比TTM



Neogenomics Inc

12.280

-0.020-0.16%

概覽公司財務分析

概覽

公司

財務

分析

關於 Neogenomics Inc 公司

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Neogenomics Inc簡介



公司代碼NEO

公司名稱Neogenomics Inc

上市日期Dec 10, 2012

CEOZook (Antony P)

員工數量2200

證券類型Ordinary Share

年結日Dec 10

公司地址9490 Neogenomics Way

城市FORT MYERS

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編33912

電話12397680600

網址https://neogenomics.com/

公司代碼NEO

上市日期Dec 10, 2012

CEOZook (Antony P)

Neogenomics Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

174.72K

-6.40%

Mr. Warren Stone

President, Chief Operating Officer

99.50K

-8.10%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Felicia Williams

Independent Director

7.16K

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

Dr. Alison L. Hannah, M.D.

Independent Director

Mr. Gregory Aunan

Chief Accounting Officer

Ms. Alicia Olivo

Executive Vice President, General Counsel & Business Development

Mr. Michael A. Kelly

Lead Independent Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

174.72K

-6.40%

Mr. Warren Stone

President, Chief Operating Officer

99.50K

-8.10%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Felicia Williams

Independent Director

7.16K

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Clinical Services-Client direct billing

131.16M

72.33%

Clinical Services-Commercial Insurance

28.77M

15.86%

Clinical Services-Medicare and Medicaid

21.39M

11.79%

Clinical Services-Self-Pay

20.00K

0.01%

由於公司未披露，未能獲取相關數據

業務

地區

業務USD

名稱

營收

佔比

Clinical Services-Client direct billing

131.16M

72.33%

Clinical Services-Commercial Insurance

28.77M

15.86%

Clinical Services-Medicare and Medicaid

21.39M

11.79%

Clinical Services-Self-Pay

20.00K

0.01%

股東統計

更新時間: 11月17日週一

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.59%

The Vanguard Group, Inc.

10.72%

First Light Asset Management, LLC

7.67%

Greenhouse Funds LLLP

6.35%

Millennium Management LLC

5.01%

其他

56.65%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.59%

The Vanguard Group, Inc.

10.72%

First Light Asset Management, LLC

7.67%

Greenhouse Funds LLLP

6.35%

Millennium Management LLC

5.01%

其他

56.65%

股東類型

持股股東

佔比

Investment Advisor

44.58%

Investment Advisor/Hedge Fund

29.42%

Hedge Fund

23.57%

Research Firm

2.99%

Pension Fund

1.27%

Individual Investor

1.26%

Bank and Trust

0.58%

Sovereign Wealth Fund

0.09%

Family Office

0.04%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

568

127.88M

98.83%

-9.78M

2025Q2

571

126.82M

98.17%

-12.95M

2025Q1

596

131.44M

102.13%

-4.71M

2024Q4

585

127.59M

99.32%

-7.82M

2024Q3

589

129.38M

100.96%

-8.76M

2024Q2

597

131.21M

102.74%

-9.36M

2024Q1

633

132.83M

104.04%

-13.13M

2023Q4

672

130.90M

102.70%

-12.18M

2023Q3

691

124.98M

98.00%

-16.78M

2023Q2

691

121.76M

95.45%

-23.63M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

17.77M

13.76%

-516.86K

-2.83%

Jun 30, 2025

The Vanguard Group, Inc.

14.10M

10.92%

-126.36K

-0.89%

Jun 30, 2025

First Light Asset Management, LLC

6.85M

5.3%

+803.61K

+13.30%

Jun 30, 2025

Greenhouse Funds LLLP

7.43M

5.75%

+2.72M

+57.83%

Jun 30, 2025

Millennium Management LLC

3.32M

2.57%

-3.40M

-50.63%

Jun 30, 2025

State Street Investment Management (US)

5.11M

3.96%

+21.77K

+0.43%

Jun 30, 2025

Deerfield Management Company, L.P.

2.15M

1.66%

+2.15M

Jun 30, 2025

Dimensional Fund Advisors, L.P.

4.29M

3.32%

+448.53K

+11.66%

Jun 30, 2025

Schroder Investment Management North America Inc.

3.72M

2.88%

-587.33K

-13.63%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

State Street SPDR S&P Health Care Services ETF

2.38%

Invesco S&P SmallCap Health Care ETF

0.77%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.5%

Inspire Small/Mid Cap ESG ETF

0.32%

iShares U.S. Healthcare Providers ETF

0.2%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

0.14%

iShares S&P Small-Cap 600 Value ETF

0.12%

Nuveen ESG Small-Cap ETF

0.11%

iShares ESG Select Screened S&P Small-Cap ETF

0.1%

iShares Core S&P Small-Cap ETF

0.09%

State Street SPDR S&P Health Care Services ETF

佔比2.38%

Invesco S&P SmallCap Health Care ETF

佔比0.77%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比0.5%

Inspire Small/Mid Cap ESG ETF

佔比0.32%

iShares U.S. Healthcare Providers ETF

佔比0.2%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

佔比0.14%

iShares S&P Small-Cap 600 Value ETF

佔比0.12%

Nuveen ESG Small-Cap ETF

佔比0.11%

iShares ESG Select Screened S&P Small-Cap ETF

佔比0.1%

iShares Core S&P Small-Cap ETF

佔比0.09%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Neogenomics Inc的前五大股東是誰？



Neogenomics Inc的前五大股東如下：
BlackRock Institutional Trust Company, N.A.
持有股份：17.77M
佔總股份比例：13.76%。
The Vanguard Group, Inc.
持有股份：14.10M
佔總股份比例：10.92%。
First Light Asset Management, LLC
持有股份：6.85M
佔總股份比例：5.30%。
Greenhouse Funds LLLP
持有股份：7.43M
佔總股份比例：5.75%。
Millennium Management LLC
持有股份：3.32M
佔總股份比例：2.57%。